{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:10:51Z","timestamp":1773184251425,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Technology R&D Program of China","award":["2019YFC1005202"],"award-info":[{"award-number":["2019YFC1005202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07608-w","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:01:59Z","timestamp":1720522919000},"page":"1315-1329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis"],"prefix":"10.1007","volume":"310","author":[{"given":"Muheng","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiurong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijian","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2994-3689","authenticated-orcid":false,"given":"Zhiqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"1","key":"7608_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7608_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO consensus on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 27(1):16\u201341","journal-title":"Ann Oncol"},{"key":"7608_CR3","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fonc.2019.01440","volume":"9","author":"S Zhang","year":"2019","unstructured":"Zhang S, Gong TT, Liu FH et al (2019) Global, regional, and national burden of endometrial cancer, 1990\u20132017: results from the global burden of disease study, 2017. Front Oncol 9:1440","journal-title":"Front Oncol"},{"issue":"1","key":"7608_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31(1):12\u201339","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"7608_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL et al (2022) Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(9):860\u2013877","journal-title":"Ann Oncol"},{"key":"7608_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jconrel.2019.11.015","volume":"316","author":"Q Bao","year":"2019","unstructured":"Bao Q, Zou Y, Wang Y et al (2019) Drug release testing of long-acting intrauterine systems. J Control Release 316:349\u2013358","journal-title":"J Control Release"},{"key":"7608_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114581","volume":"191","author":"S Fanse","year":"2022","unstructured":"Fanse S, Bao Q, Burgess DJ (2022) Long-acting intrauterine systems: recent advances, current challenges, and future opportunities. Adv Drug Deliv Rev 191:114581","journal-title":"Adv Drug Deliv Rev"},{"key":"7608_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejogrb.2021.06.007","volume":"263","author":"S Piatek","year":"2021","unstructured":"Piatek S, Michalski W, Sobiczewski P et al (2021) The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: case series of 30 patients and systematic review. Eur J Obstet Gynecol Reprod Biol 263:139\u2013147","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"7608_CR9","doi-asserted-by":"publisher","first-page":"358.e351","DOI":"10.1016\/j.ajog.2013.06.031","volume":"209","author":"MK Kim","year":"2013","unstructured":"Kim MK, Seong SJ, Kim YS et al (2013) Combined medroxyprogesterone acetate\/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol 209(4):358.e351\u2013354","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7608_CR10","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3802\/jgo.2019.30.e57","volume":"30","author":"UL Maggiore","year":"2019","unstructured":"Maggiore UL, Martinelli F, Dondi G et al (2019) Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study. J Gynecol Oncol 30(4):e57","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"7608_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygyno.2021.01.001","volume":"161","author":"OV Novikova","year":"2021","unstructured":"Novikova OV, Nosov VB, Panov VA et al (2021) Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer. Gynecol Oncol 161(1):152\u2013159","journal-title":"Gynecol Oncol"},{"issue":"11","key":"7608_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784","journal-title":"Ann Intern Med"},{"issue":"3","key":"7608_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A et al (2001) Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dement Geriatr Cogn Disord 12(3):232\u2013236","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"46","key":"7608_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013061","volume":"97","author":"B Su","year":"2018","unstructured":"Su B, Qin W, Xue F et al (2018) The relation of passive smoking with cervical cancer: s systematic review and meta-analysis. Medicine (Baltimore) 97(46):e13061","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"7608_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","volume":"7","author":"SP Brooks","year":"1998","unstructured":"Brooks SP, Gelman A (1998) General Methods for Monitoring Convergence of Iterative Simulations. J Comput Graph Stat 7(4):434\u2013455","journal-title":"J Comput Graph Stat"},{"key":"7608_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jclinepi.2016.02.016","volume":"76","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Straus SE, Fyraridis A et al (2016) The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes. J Clin Epidemiol 76:193\u2013199","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"7608_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1018598421607","volume":"7","author":"AP Dempster","year":"1997","unstructured":"Dempster AP (1997) The direct use of likelihood for significance testing. Stat Comput 7(4):247\u2013252","journal-title":"Stat Comput"},{"issue":"7","key":"7608_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","volume":"31","author":"DT Wheeler","year":"2007","unstructured":"Wheeler DT, Bristow RE, Kurman RJ (2007) Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31(7):988\u2013998","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"7608_CR19","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/humrep\/det320","volume":"28","author":"ID Gallos","year":"2013","unstructured":"Gallos ID, Krishan P, Shehmar M et al (2013) LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Hum Reprod 28(11):2966\u20132971","journal-title":"Hum Reprod"},{"issue":"5","key":"7608_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/humrep\/det049","volume":"28","author":"ID Gallos","year":"2013","unstructured":"Gallos ID, Krishan P, Shehmar M et al (2013) Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Hum Reprod 28(5):1231\u20131236","journal-title":"Hum Reprod"},{"issue":"6","key":"7608_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/ajo.12142","volume":"53","author":"TJ Cade","year":"2013","unstructured":"Cade TJ, Quinn MA, Rome RM et al (2013) Long-term outcomes after progestogen treatment for early endometrial cancer. Aust N Z J Obstet Gynaecol 53(6):566\u2013570","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"7608_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3802\/jgo.2013.24.2.128","volume":"24","author":"H Abu Hashim","year":"2013","unstructured":"Abu Hashim H, Zayed A, Ghayaty E et al (2013) LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial. J Gynecol Oncol 24(2):128\u2013134","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"7608_CR23","first-page":"122","volume":"40","author":"K Dolapcioglu","year":"2013","unstructured":"Dolapcioglu K, Boz A, Baloglu A (2013) The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. a prospective randomized comparative study. Clin Exp Obstet Gynecol 40(1):122\u2013126","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"7608_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1933719112459243","volume":"20","author":"MT Ismail","year":"2013","unstructured":"Ismail MT, Fahmy DM, Elshmaa NS (2013) Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia. Reprod Sci 20(1):45\u201350","journal-title":"Reprod Sci"},{"issue":"6","key":"7608_CR25","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/AOG.0b013e31828d6186","volume":"121","author":"JL Hubbs","year":"2013","unstructured":"Hubbs JL, Saig RM, Abaid LN et al (2013) Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma. Obstet Gynecol 121(6):1172\u20131180","journal-title":"Obstet Gynecol"},{"issue":"3","key":"7608_CR26","first-page":"421","volume":"40","author":"M Karimi-Zarchi","year":"2013","unstructured":"Karimi-Zarchi M, Dehghani-Firoozabadi R, Tabatabaie A et al (2013) A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation. Clin Exp Obstet Gynecol 40(3):421\u2013424","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"4","key":"7608_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1471-0528.12499","volume":"121","author":"A \u00d8rbo","year":"2014","unstructured":"\u00d8rbo A, Vereide A, Arnes M et al (2014) Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. BJOG 121(4):477\u2013486","journal-title":"BJOG"},{"issue":"8","key":"7608_CR28","first-page":"686","volume":"19","author":"F Behnamfar","year":"2014","unstructured":"Behnamfar F, Ghahiri A, Tavakoli M (2014) Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia. J Res Med Sci 19(8):686\u2013690","journal-title":"J Res Med Sci"},{"issue":"3","key":"7608_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1933719114542014","volume":"22","author":"MM El Behery","year":"2015","unstructured":"El Behery MM, Saleh HS, Ibrahiem MA et al (2015) Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia. Reprod Sci 22(3):329\u2013334","journal-title":"Reprod Sci"},{"issue":"9","key":"7608_CR30","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/1471-0528.13763","volume":"123","author":"A \u00d8rbo","year":"2016","unstructured":"\u00d8rbo A, Arnes M, Vereide AB et al (2016) Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG 123(9):1512\u20131519","journal-title":"BJOG"},{"key":"7608_CR31","first-page":"353","volume":"5","author":"M Rezk","year":"2016","unstructured":"Rezk M, Mohamed KAA et al (2016) Comparison of levonorgestrel-releasing intrauterine system, medroxyprogesterone and norethisterone for treatment of endometrial hyperplasia without atypia: a randomized. Clin Trial 5:353\u2013356","journal-title":"Clin Trial"},{"key":"7608_CR32","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e2","author":"F Falcone","year":"2017","unstructured":"Falcone F, Laurelli G, Losito S et al (2017) Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol. https:\/\/doi.org\/10.3802\/jgo.2017.28.e2","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"7608_CR33","first-page":"675","volume":"12","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Ghaffar S, Haider R et al (2018) Levonorgestril intrauterine system (LNG-IUS) versus medroxyprogesterone acetate for the treatment of endometrial hyperplasia: a randomized control trial. Pak J Med Health Sci 12(2):675\u2013678","journal-title":"Pak J Med Health Sci"},{"issue":"3","key":"7608_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00404-019-05059-2","volume":"299","author":"MA Ciccone","year":"2019","unstructured":"Ciccone MA, Whitman SA, Conturie CL et al (2019) Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia. Arch Gynecol Obstet 299(3):801\u2013808","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"7608_CR35","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e74","volume":"31","author":"F Falcone","year":"2020","unstructured":"Falcone F, Maggiore LR et al (2020) Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study. J Gynecol Oncol 31(5):e74","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"7608_CR36","doi-asserted-by":"publisher","first-page":"103.e101","DOI":"10.1016\/j.ajog.2019.12.273","volume":"223","author":"RS Mandelbaum","year":"2020","unstructured":"Mandelbaum RS, Ciccone MA, Nusbaum DJ et al (2020) Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy. Am J Obstet Gynecol 223(1):103.e101-103.e113","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"7608_CR37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/ijgc-2020-001362","volume":"30","author":"K Matsuo","year":"2020","unstructured":"Matsuo K, Mandelbaum RS, Ciccone M et al (2020) Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia. Int J Gynecol Cancer 30(9):1331\u20131339","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"7608_CR38","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.rbmo.2021.08.022","volume":"43","author":"G Campo","year":"2021","unstructured":"Campo G, Rebecchi A, Vanni VS et al (2021) Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia. Reprod Biomed Online 43(5):864\u2013870","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"7608_CR39","doi-asserted-by":"publisher","first-page":"983","DOI":"10.31557\/APJCP.2021.22.3.983","volume":"22","author":"RD Ravi","year":"2021","unstructured":"Ravi RD, Kalra J, Srinivasan R et al (2021) A randomized clinical trial of levonorgestrel intrauterine system with or without metformin for treatment of endometrial hyperplasia without atypia in indian women. Asian Pac J Cancer Prev 22(3):983\u2013989","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"7608_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12150","volume":"8","author":"Y Shen","year":"2022","unstructured":"Shen Y, Fang H, Zhang Y et al (2022) Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia. Heliyon 8(12):e12150","journal-title":"Heliyon"},{"issue":"1","key":"7608_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43043-023-00145-7","volume":"28","author":"OT Taha","year":"2023","unstructured":"Taha OT, Abd-Elgelil MM, Kishk EA et al (2023) Metformin versus levonorgestrel-releasing intrauterine system in the management of endometrial hyperplasia: a randomized clinical trial. Middle East Fertil Soc J 28(1):20","journal-title":"Middle East Fertil Soc J"},{"issue":"1","key":"7608_CR42","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.3802\/jgo.2023.34.e32","volume":"34","author":"Z Xu","year":"2023","unstructured":"Xu Z, Yang B, Guan J et al (2023) Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914). J Gynecol Oncol 34(1):e32","journal-title":"J Gynecol Oncol"},{"key":"7608_CR43","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e62","author":"AA Alnemr","year":"2024","unstructured":"Alnemr AA, Harb OA, Atia H (2024) The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial. J Gynecol Oncol. https:\/\/doi.org\/10.3802\/jgo.2024.35.e62","journal-title":"J Gynecol Oncol"},{"key":"7608_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2024.03.017","volume":"183","author":"NK Kim","year":"2024","unstructured":"Kim NK, Choi CH, Seong SJ et al (2024) Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia\/endometrial intraepithelial neoplasia-Multicenter retrospective study (KGOG2033). Gynecol Oncol 183:68\u201373. https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.017","journal-title":"Gynecol Oncol"},{"issue":"5","key":"7608_CR45","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1245\/s10434-016-5699-9","volume":"24","author":"JS Yuk","year":"2017","unstructured":"Yuk JS, Song JY, Lee JH et al (2017) Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis. Ann Surg Oncol 24(5):1322\u20131329","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"7608_CR46","first-page":"cd012658","volume":"9","author":"T Mittermeier","year":"2020","unstructured":"Mittermeier T, Farrant C, Wise MR (2020) Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database Syst Rev 9(9):cd012658","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"7608_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/1471-0528.17331","volume":"130","author":"WJ van Weelden","year":"2023","unstructured":"van Weelden WJ, Birkendahl PB, Lalisang RI et al (2023) The effect of progestin therapy in advanced and recurrent endometrial cancer: a systematic review and meta-analysis. BJOG 130(2):143\u2013152","journal-title":"BJOG"},{"issue":"8","key":"7608_CR48","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3390\/jcm12082980","volume":"12","author":"YF Zhang","year":"2023","unstructured":"Zhang YF, Fan Y, Mu Y et al (2023) Efficacy of oral medications or intrauterine device-delivered progestin in patients with endometrial hyperplasia with or without atypia: a network meta-analysis. J Clin Med 12(8):2980","journal-title":"J Clin Med"},{"key":"7608_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","volume":"273","author":"S De Rocco","year":"2022","unstructured":"De Rocco S, Buca D, Oronzii L et al (2022) Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 273:90\u201397","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7608_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bpobgyn.2020.05.003","volume":"69","author":"A Gompel","year":"2020","unstructured":"Gompel A (2020) Progesterone and endometrial cancer. Best Pract Res Clin Obstet Gynaecol 69:95\u2013107","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"7608_CR51","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e49","volume":"34","author":"I Murakami","year":"2023","unstructured":"Murakami I, Machida H, Morisada T et al (2023) Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review. J Gynecol Oncol 34(4):e49","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"7608_CR52","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00404-023-07077-7","volume":"308","author":"H Ga","year":"2023","unstructured":"Ga H, Taguchi A, Honjoh H et al (2023) Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy. Arch Gynecol Obstet 308(5):1629\u20131634","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"7608_CR53","first-page":"Cd009458","volume":"12","author":"L Luo","year":"2018","unstructured":"Luo L, Luo B, Zheng Y et al (2018) Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Database Syst Rev 12(12):Cd009458","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"7608_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s43032-019-00019-2","volume":"27","author":"JMP Pabona","year":"2020","unstructured":"Pabona JMP, Burnett AF, Brown DM et al (2020) Metformin promotes anti-tumor biomarkers in human endometrial cancer cells. Reprod Sci 27(1):267\u2013277","journal-title":"Reprod Sci"},{"issue":"6","key":"7608_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101863","volume":"50","author":"A Tehranian","year":"2021","unstructured":"Tehranian A, Ghahghaei-Nezamabadi A, Arab M et al (2021) The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial. J Gynecol Obstet Hum Reprod 50(6):101863","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"12","key":"7608_CR56","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.21037\/tcr-20-2092","volume":"9","author":"SG Vitale","year":"2020","unstructured":"Vitale SG, Riemma G, Carugno J et al (2020) Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives. Transl Cancer Res 9(12):7767\u20137777","journal-title":"Transl Cancer Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07608-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T02:06:08Z","timestamp":1725242768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07608-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["7608"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07608-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}